Tirzepatide Dispensations Increased Rapidly After Approval

By December 2023, 12.3 percent of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM
injector needle injection pen
Adobe Stock
Medically Reviewed By:
Farrokh Sohrabi, M.D.
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com